Townsquare Capital LLC Argenx Se Transaction History

Townsquare Capital LLC

$8.15 Billion
Q3 2024

A detailed history of Townsquare Capital LLC transactions in Argenx Se stock. As of the latest transaction made, Townsquare Capital LLC holds 4,307 shares of ARGX stock, worth $2.7 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

4,307

Previous 4,321 0.32%

Holding current value

$2.7 Million

Previous $1.86 Million 25.67%

% of portfolio

0.03%

Previous 0.03%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$434.22 - $551.9 $6,079 - $7,726	-14 Reduced 0.32%	4,307 $2.34 Million
Q2 2024 Aug 14, 2024	BUY	$356.01 - $451.55 $64,793 - $82,182	182 Added 4.4%	4,321 $1.86 Million
Q1 2024 May 15, 2024	SELL	$356.95 - $413.29 $110,297 - $127,706	-309 Reduced 6.95%	4,139 $1.63 Million
Q4 2023 Feb 15, 2024	BUY	$338.91 - $506.01 $340,943 - $509,046	1,006 Added 29.23%	4,448 $1.69 Million
Q3 2023 Nov 15, 2023	BUY	$369.35 - $548.43 $624,570 - $927,395	1,691 Added 96.57%	3,442 $1.69 Million
Q2 2023 Nov 13, 2023	BUY	$360.14 - $422.58 $61,583 - $72,261	171 Added 10.82%	1,751 $682,000
Q1 2023 May 11, 2023	BUY	$334.23 - $403.65 $16,377 - $19,778	49 Added 3.2%	1,580 $588,000
Q4 2022 Feb 13, 2023	BUY	$342.17 - $402.31 $240,887 - $283,226	704 Added 85.13%	1,531 $579,000
Q3 2022 Nov 10, 2022	BUY	$343.2 - $395.75 $59,030 - $68,069	172 Added 26.26%	827 $292,000
Q2 2022 Aug 08, 2022	SELL	$269.58 - $378.88 $539 - $757	-2 Reduced 0.3%	655 $248,000
Q1 2022 Apr 28, 2022	BUY	$254.45 - $351.06 $508 - $702	2 Added 0.31%	657 $207,000
Q4 2021 Feb 11, 2022	BUY	$272.01 - $353.03 $178,166 - $231,234	655 New	655 $229,000
Q3 2021 Nov 15, 2021	SELL	$295.0 - $350.58 $193,225 - $229,629	-655 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$257.11 - $319.92 $274,593 - $341,674	-1,068 Reduced 61.98%	655 $204,000
Q1 2021 May 17, 2021	SELL	$268.3 - $380.31 $672,628 - $953,437	-2,507 Reduced 59.27%	1,723 $474,000
Q4 2020 Feb 16, 2021	BUY	$248.13 - $308.36 $286,342 - $355,847	1,154 Added 37.52%	4,230 $1.25 Million
Q3 2020 Dec 01, 2020	BUY	$215.51 - $272.51 $164,649 - $208,197	764 Added 33.04%	3,076 $825,000
Q2 2020 Aug 17, 2020	SELL	$127.44 - $232.72 $1,656 - $3,025	-13 Reduced 0.56%	2,312 $580,000
Q1 2020 May 18, 2020	SELL	$108.83 - $165.23 $73,133 - $111,034	-672 Reduced 22.42%	2,325 $338,000
Q4 2019 May 18, 2020	BUY	$106.59 - $164.21 $3,837 - $5,911	36 Added 1.22%	2,997 $481,000
Q3 2019 Nov 14, 2019	BUY	$113.31 - $150.51 $4,532 - $6,020	40 Added 1.37%	2,961 $370,000
Q2 2019 Aug 15, 2019	SELL	$115.0 - $141.58 $43,930 - $54,083	-382 Reduced 11.57%	2,921 $417,000
Q1 2019 May 15, 2019	BUY	$98.85 - $134.59 $84,912 - $115,612	859 Added 35.15%	3,303 $412,000
Q4 2018 Feb 13, 2019	BUY	$63.81 - $109.82 $155,951 - $268,400	2,444 New	2,444 $273,000

Others Institutions Holding ARGX

# of Institutions

400

Shares Held

30.9M

Call Options Held

376K

Put Options Held

489K

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $34.6B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Townsquare Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Townsquare Capital LLC with notifications on news.

Account

Townsquare Capital LLC Argenx Se Transaction History